The innovative medicines initiative: a European response to the innovation challenge.
about
The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholdersPrecompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson's DiseaseDrug discovery in paediatric oncology: roadblocks to progress.The Ethical Significance of Antimicrobial Resistance.Public-private partnerships as driving forces in the quest for innovative medicinesTranslational genomics.The innovative medicines initiative: a public private partnership model to foster drug discovery.Advancing the science of medicines regulation: the role of the 21st-century medicines regulator.The Innovative Medicines Initiative moves translational immunology forward.Defining "innovativeness" in drug development: a systematic review.An evaluation of regulatory and commercial barriers to stratified medicine development and adoption.Building the Human Vaccines Project: strategic management recommendations and summary report of the 15-16 July 2014 business workshop.Academic drug discovery: current status and prospects.Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact.The future of population-based postmarket drug risk assessment: a regulator's perspective.Exploring bacterial outer membrane barrier to combat bad bugs.Public-private partnerships to revitalize psychiatric drug discovery."Collaborative innovation"--regaining the edge in drug discovery.Developing doctoral scientists for drug discovery: pluridimensional education required.The innovative medicines initiative: a case study for new ways of working in drug R&D.Open Innovation in Drug Discovery.The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project
P2860
Q28543430-5885D877-CFAB-4D31-8495-DAE5E496CF7EQ28601965-D1AA78A3-6921-434D-95FE-7D84068417B2Q36262295-92E7011A-7EDB-4CFB-967F-31845E0CF55CQ36263119-2C5A42A9-C5CE-4DD3-95D2-73F1885D85BFQ36588385-5CAA33F6-7CED-44A2-8BEB-1E526BED93DCQ36950760-5D5A5CD7-D845-4356-9902-4C7B3A1A6BFEQ37655104-8EFAE2FD-5FA0-4631-8F05-7E6EA19DAEC0Q38040696-253F7543-4175-4A17-BB47-6D4E49B927B3Q38093624-DBDC77F6-CCF2-4BAC-AD28-5D2FFADDBB39Q38110722-CE5E632B-36D3-474B-B4EC-896BB3F4B2E4Q38257149-1E0D22B7-D5AF-4DBB-9023-C64A163E3B23Q38352326-669E3E23-5DCD-4AA3-B787-40B7B3DD8162Q38389070-F1BE8F16-F1CC-452D-9CEE-C3E8226D73E0Q38673910-851DF933-1EF7-4223-8D8F-A79ED10F9B49Q39406884-8C64E7D8-CE21-42AE-A103-B53BB27B1CFBQ41633774-0EEB90F3-18B5-4DED-B7D2-D3781594689AQ44884838-B3B3AAA8-5FD9-45B4-B449-2CC7F5087137Q46670214-F1E3F88C-0A80-40B3-91B3-3FD6912C5A27Q50889409-5D29C273-B80A-4360-9E1C-309EBB6AD6C8Q51290692-C61F2C5D-7EBF-46B6-999C-6E9A87F6911DQ54625820-40F2E8F4-9319-4100-953A-7DBB7793BAE2Q58050593-8A01220D-1664-40AB-8A5A-7492A2CAC9F6
P2860
The innovative medicines initiative: a European response to the innovation challenge.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The innovative medicines initiative: a European response to the innovation challenge.
@ast
The innovative medicines initiative: a European response to the innovation challenge.
@en
The innovative medicines initiative: a European response to the innovation challenge.
@nl
type
label
The innovative medicines initiative: a European response to the innovation challenge.
@ast
The innovative medicines initiative: a European response to the innovation challenge.
@en
The innovative medicines initiative: a European response to the innovation challenge.
@nl
prefLabel
The innovative medicines initiative: a European response to the innovation challenge.
@ast
The innovative medicines initiative: a European response to the innovation challenge.
@en
The innovative medicines initiative: a European response to the innovation challenge.
@nl
P2860
P356
P1476
The innovative medicines initiative: a European response to the innovation challenge.
@en
P2093
P2860
P304
P356
10.1038/CLPT.2011.321
P407
P577
2012-02-08T00:00:00Z